iBio, Inc. (IBIO)
2.25
-0.14
(-5.86%)
USD |
NASDAQ |
Jan 23, 16:00
2.255
0.00 (0.00%)
After-Hours: 20:00
iBio Total Assets (Quarterly): 64.16M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Bionano Genomics, Inc. | 79.06M |
| Vor Biopharma, Inc. | 176.24M |
| Recursion Pharmaceuticals, Inc. | 1.400B |
| Senti Biosciences, Inc. | 52.68M |
| NovaBay Pharmaceuticals, Inc. | 3.487M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 8.116M |
| Shareholders Equity (Quarterly) | 56.04M |
| Debt to Equity Ratio | 0.0588 |
| Current Ratio | 8.395 |
| Net Debt Paydown Yield | 1.39% |